Details

Autor(en) / Beteiligte

• Chang, Hung-Yu
• Wang, Chun-Chieh
• Wu, Yen-Wen
• Chu, Pao-Hsien
• Wu, Chih-Cheng
• Hsu, Chih-Hsin
• Wen, Ming-Shien
• Voon, Wen-Chol
• Lin, Wei-Shiang
• Huang, Jin-Long
• Chen, Shyh-Ming
• Yang, Ning-I
• Chang, Heng-Chia
• Chang, Kuan-Cheng
• Sung, Shih-Hsien
• Shyu, Kou-Gi
• Lin, Jiunn-Lee
• Mar, Guang-Yuan
• Chan, Kuei-Chuan
• Kuo, Jen-Yuan
• Wang, Ji-Hung
• Chen, Zhih-Cherng
• Tseng, Wei-Kung
• Cherng, Wen-Jin
• Yin, Wei-Hsian

Titel

One-Year Outcomes of Acute Decompensated Systolic Heart Failure in Taiwan: Lessons from TSOC-HFrEF Registry

Ist Teil von

• Acta Cardiologica Sinica, 2017-03, Vol.33 (2), p.127-138

Ort / Verlag

台灣: 中華民國心臟學會

Erscheinungsjahr

2017

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• Background: Heart failure (HF) is a global health problem. The Taiwan Society of Cardiology-Heart Failure with reduced Ejection Fraction (TSOC-HFrEF) registry was a multicenter, observational survey of patients admitted with HFrEF in Taiwan. The aim of this study was to report the one-year outcome in this large-cohort of hospitalized patients presenting with acute decompensated HFrEF. Methods: Patients hospitalized for acute HFrEF were recruited in 21 hospitals in Taiwan. A total of 1509 patients were enrolled into the registry by the end of October 2014. Clinical status, readmission rates and dispensed medications were collected and analyzed 1 year after patient index hospitalization. Results: Our study indicated that re-hospitalization rates after HFrEF were 31.9% and 38.5% at 6 and 12 months after index hospitalization, respectively. Of these patients, 9.7% of themwere readmittedmore than once. At 6 and 12 months after hospital discharge, all-cause mortality rates were 9.5% and 15.9%, respectively, and cardiovascular mortality rateswere 6.8% and 10.5%, respectively. Twenty-three patients (1.5%) underwent heart transplantation. During a follow-up period of 1 year, 46.4% of patients were free from mortality, HF re-hospitalization, left ventricular assist device use and heart transplantation. At the conclusion of follow-up, 57.5% of patients were prescribed either with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers; also, 66.3% were prescribed with beta-blockers and 40.8% were prescribed with mineralocorticoid receptor antagonists. Conclusions: The TSOC-HFrEF registry showed evidence of suboptimal practice of guideline-directed medical therapy and high HF re-hospitalization rate in Taiwan. The one-year mortality rate of the TSOC-HFrEF registry remained high. Ultimately, our data indicated a need for further improvement in HF care.